Elutia regains full compliance with Nasdaq minimum bid price and MVLS requirements

ELUTIA INC.

Received Nasdaq notice on March 2, 2026, confirming compliance with minimum bid price rule (bid ≥ $1.00 for 10 consecutive days).
Received Nasdaq notice on February 5, 2026, confirming compliance with MVLS requirement (MVLS ≥ $35M for 11 consecutive days).
All Nasdaq continued listing requirements are now met; matters are closed; stock continues trading on Nasdaq Capital Market under symbol ELUT.
CFO Matt Ferguson cites investor confidence in drug-eluting biomatrix technology platform and market opportunity.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.